Blood Clots Should Be Listed As Rare AstraZeneca Side Effect: European Medicines Agency

0

“EMA’s safety committee has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects” of the shot, the Amsterdam-based EU drug regulator said in a statement.

Blood Clots Should Be Listed As Rare AstraZeneca Side Effect: European Medicines Agency

European Medicines Agencythat blood clots should be listed as a “very rare” side effect



The Hague, Netherlands:

The European Medicines Agency said Wednesday that blood clots should be listed as a “very rare” side effect of the AstraZeneca coronavirus vaccine but that the jab’s benefits continue to outweigh the risks.

“EMA’s safety committee has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects” of the shot, the Amsterdam-based EU drug regulator said in a statement.

(Except for the headline, this story has not been edited by our staff and is published from a syndicated feed.)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

All the data shown above will be stored by www.rajpostexam.com on https://www.rajpostexam.com/. At any point of time, you can contact us and select the data you wish to anonymise or delete so it cannot be linked to your email address any longer. When your data is anonymised or deleted, you will receive an email confirmation. We also use cookies and/or similar technologies to analyse customer behaviour, administer the website, track users' movements, and to collect information about users. This is done in order to personalise and enhance your experience with us. Click here to read our Cookie Policy.